Becton, Dickinson and Co.
BDX Real Time Price USDRecent trades of BDX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in BDX holdings by institutional investors
Quarterly net insider trading by BDX's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More about Alpha -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More about Annual Standard Deviation -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More about Annual Volatility -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More about Beta -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More about CAGR -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More about Information Ratio -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More about Max Drawdown -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More about Sharpe Ratio -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More about Treynor Ratio -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$1,496,000 Jan 15, 2026 Issue: Health Issues Taxation/Internal Revenue Code Budget/Appropriations Trade (domestic/foreign) Medicare/Medicaid
-
$550,000 Oct 17, 2025 Issue: Health Issues Taxation/Internal Revenue Code Budget/Appropriations Trade (domestic/foreign) Medicare/Medicaid
-
$1,438,000 Oct 14, 2025 Issue: Health Issues Taxation/Internal Revenue Code Budget/Appropriations Trade (domestic/foreign)
-
$557,000 Sep 15, 2025 Issue: Health Issues Taxation/Internal Revenue Code Budget/Appropriations Trade (domestic/foreign)
-
$485,000 Jan 21, 2025 Issue: Budget/Appropriations Trade (domestic/foreign) Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
-
$400,000 Oct 21, 2024 Issue: Trade (domestic/foreign) Budget/Appropriations Taxation/Internal Revenue Code Health Issues
-
$427,000 Jul 22, 2024 Issue: Trade (domestic/foreign) Budget/Appropriations Taxation/Internal Revenue Code Health Issues
-
$60,000 Feb 07, 2024 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues Budget/Appropriations
-
$60,000 Jan 22, 2024 Issue: Health Issues
-
$10,000 Oct 19, 2023 Issue: Trade (domestic/foreign)
-
$80,000 Oct 18, 2023 Issue: Health Issues
-
$60,000 Oct 17, 2023 Issue: Environment/Superfund Medicare/Medicaid Health Issues Budget/Appropriations
-
$10,000 Oct 06, 2023 Issue: Trade (domestic/foreign)
-
$80,000 Jul 20, 2023 Issue: Health Issues
-
$60,000 Jul 17, 2023 Issue: Environment/Superfund Medicare/Medicaid Health Issues Budget/Appropriations
-
$80,000 Jan 20, 2023 Issue: Health Issues
-
$60,000 Jan 20, 2023 Issue: Health Issues
-
$20,000 Jan 10, 2023 Issue: Health Issues
-
$80,000 Oct 20, 2022 Issue: Health Issues
-
$60,000 Oct 20, 2022 Issue: Health Issues
-
$60,000 Oct 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues Budget/Appropriations
-
$50,000 Oct 19, 2022 Issue: Health Issues
-
$50,000 Jul 21, 2022 Issue: Health Issues
-
$80,000 Jul 20, 2022 Issue: Health Issues
-
$60,000 Jul 19, 2022 Issue: Budget/Appropriations Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
-
$60,000 Jul 18, 2022 Issue: Health Issues
-
$80,000 Apr 20, 2022 Issue: Health Issues
-
$60,000 Apr 15, 2022 Issue: Health Issues
-
$60,000 Apr 14, 2022 Issue: Budget/Appropriations Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
-
$50,000 Apr 11, 2022 Issue: Health Issues
-
$80,000 Jan 20, 2022 Issue: Health Issues
-
$60,000 Jan 19, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid Health Issues Budget/Appropriations
-
$40,000 Jan 18, 2022 Issue: Health Issues
-
$60,000 Jan 15, 2022 Issue: Health Issues
-
$80,000 Oct 20, 2021 Issue: Health Issues
-
$40,000 Oct 20, 2021 Issue: Health Issues
-
$60,000 Oct 18, 2021 Issue: Health Issues
-
$60,000 Oct 18, 2021 Issue: Health Issues Budget/Appropriations Taxation/Internal Revenue Code Medicare/Medicaid
-
$100,000 Feb 12, 2007 Issue: Budget/Appropriations Health Issues
-
$100,000 Aug 07, 2006 Issue: Budget/Appropriations
-
$80,000 Feb 09, 2006 Issue: Budget/Appropriations
-
$100,000 Aug 15, 2005 Issue: Health Issues Budget/Appropriations
-
$240,000 Aug 15, 2005 Issue: Health Issues
-
$20,000 Aug 08, 2005 Issue: Taxation/Internal Revenue Code
-
$440,000 Aug 26, 2004 Issue: Health Issues
-
$340,000 Apr 13, 2004 Issue: Health Issues
-
$260,000 Aug 15, 2003 Issue: Health Issues
-
$180,000 Mar 03, 2003 Issue: Health Issues
-
$260,000 Aug 14, 2002 Issue: Health Issues
-
$200,000 Feb 14, 2002 Issue: Health Issues
-
$140,000 Aug 22, 2001 Issue: Health Issues
-
$160,000 Feb 15, 2001 Issue: Health Issues
-
$160,000 Aug 15, 2000 Issue: Health Issues
-
$80,000 Feb 16, 2000 Issue: Health Issues
BDX Estimated quarterly lobbying spending
BDX Revenue by Segment or Geography
New BDX patent grants
-
Patent Title: Microinfuser Aug. 19, 2014
-
Patent Title: Soft cap for a connector Aug. 05, 2014
-
Patent Title: Package portion for a medical product Jul. 29, 2014
-
Patent Title: Process tube strip Jul. 22, 2014
-
Patent Title: Process tube Jul. 22, 2014
-
Patent Title: Soft cap for a connector Jul. 08, 2014
-
Patent Title: Autoinjector Jul. 01, 2014
-
Patent Title: Self injection device Apr. 22, 2014
-
Patent Title: Container cover Feb. 18, 2014
-
Patent Title: Autoinjector Jan. 07, 2014
-
Patent Title: Autoinjector Dec. 31, 2013
-
Patent Title: Autoinjector Dec. 31, 2013
-
Patent Title: Self injection device Dec. 31, 2013
-
Patent Title: Autoinjector Dec. 31, 2013
-
Patent Title: Self injection device Dec. 31, 2013
-
Patent Title: Autoinjector Dec. 31, 2013
-
Patent Title: Autoinjector Dec. 24, 2013
-
Patent Title: Container cap Dec. 03, 2013
-
Patent Title: Cap portion of a vial Nov. 19, 2013
-
Patent Title: Microinfuser Nov. 12, 2013
-
Patent Title: Single piece reagent holder Oct. 22, 2013
-
Patent Title: Cap portion of a vial Oct. 01, 2013
-
Patent Title: Vessel assembly Oct. 01, 2013
-
Patent Title: Plunger rod having retaining anchors Oct. 01, 2013
-
Patent Title: Closure for a specimen container having an indicator surface Sep. 24, 2013
-
Patent Title: Self-injection device Aug. 27, 2013
-
Patent Title: Self-injection device Aug. 27, 2013
-
Patent Title: Self-injection device Aug. 27, 2013
-
Patent Title: Self-injection device Aug. 27, 2013
-
Patent Title: Infusion device Aug. 27, 2013
-
Patent Title: Medical injector pen Aug. 06, 2013
-
Patent Title: Infusion device Aug. 06, 2013
-
Patent Title: Infusion device Jul. 30, 2013
-
Patent Title: Infusion device Jul. 30, 2013
-
Patent Title: Infusion device Jun. 25, 2013
-
Patent Title: Infusion device Jun. 25, 2013
-
Patent Title: Infusion device button Jun. 18, 2013
-
Patent Title: Infusion device button Jun. 18, 2013
-
Patent Title: Self injection device window Apr. 23, 2013
-
Patent Title: Self injection device Feb. 26, 2013
-
Patent Title: Sort chamber Feb. 19, 2013
-
Patent Title: Medical injector pen Feb. 19, 2013
-
Patent Title: Medical injector pen Feb. 19, 2013
-
Patent Title: Medical injector pen Feb. 19, 2013
-
Patent Title: Medical injector pen Feb. 12, 2013
-
Patent Title: Syringe plunger rod Jan. 01, 2013
-
Patent Title: Syringe plunger rod Dec. 25, 2012
-
Patent Title: Diamond shaped flask Oct. 09, 2012
-
Patent Title: Canteen shaped flask Oct. 09, 2012
-
Patent Title: Octagon shaped flask Oct. 09, 2012
Federal grants, loans, and purchases
Estimated quarterly amount awarded to BDX from public contracts
Recent insights relating to BDX
Recent picks made for BDX stock on CNBC
ETFs with the largest estimated holdings in BDX
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $BDX stock a Buy, Sell, or Hold?
- What is the price target for $BDX stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $BDX stock?
- Who owns the most shares of $BDX stock?
- What funds own $BDX stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view BDX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.
- Address Franklin Lakes, NJ
- Market Cap 44.8 billion
- Employees 72,000
- Industrial Classification Surgical & Medical Instruments & Apparatus
|
Name
|
Role
|
Salary
|
Bonus
|
Stock/Option Awards
|
Total Compensation
|
|---|